Slower progression of amyotrophic lateral sclerosis with external application of a Chinese herbal plaster–The randomized, placebo-controlled triple-blinded ALS-CHEPLA trial

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a chronic neurodegenerative disease characterized by gradually increasing damage to the upper and lower motor neurons. However, definitive and efficacious treatment for ALS is not available, and oral intake in ALS patients with bulbar involvement is...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröder, Sven, Wang, Mingzhe, Sima, Dandan, Schröder, Joana, Zhu, Xuying, Zheng, Xuanlu, Liu, Lin, Li, Tingying, Wang, Qiudong, Friedemann, Thomas, Liu, Te, Pan, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620479/
https://www.ncbi.nlm.nih.gov/pubmed/36324375
http://dx.doi.org/10.3389/fneur.2022.990802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620479/
https://www.ncbi.nlm.nih.gov/pubmed/36324375
http://dx.doi.org/10.3389/fneur.2022.990802

Ejemplares similares